VIRGINIA RETIREMENT SYSTEMS ET Al Invests $1.63 Million in Doximity, Inc. $DOCS

VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Doximity, Inc. (NASDAQ:DOCSFree Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 26,533 shares of the company’s stock, valued at approximately $1,628,000.

Several other institutional investors have also modified their holdings of the company. Vanguard Group Inc. boosted its stake in shares of Doximity by 8.8% during the 1st quarter. Vanguard Group Inc. now owns 12,194,492 shares of the company’s stock worth $707,646,000 after acquiring an additional 990,923 shares in the last quarter. William Blair Investment Management LLC boosted its stake in shares of Doximity by 13.8% during the 2nd quarter. William Blair Investment Management LLC now owns 5,219,394 shares of the company’s stock worth $320,158,000 after acquiring an additional 634,927 shares in the last quarter. Invesco Ltd. boosted its stake in shares of Doximity by 54.8% during the 1st quarter. Invesco Ltd. now owns 1,969,326 shares of the company’s stock worth $114,280,000 after acquiring an additional 696,923 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Doximity by 130.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,966,801 shares of the company’s stock worth $114,133,000 after acquiring an additional 1,113,076 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. boosted its stake in shares of Doximity by 9.5% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 1,730,282 shares of the company’s stock worth $100,408,000 after acquiring an additional 150,574 shares in the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently issued reports on DOCS. Wells Fargo & Company upped their target price on Doximity from $55.00 to $62.00 and gave the company an “equal weight” rating in a research note on Monday, August 4th. Bank of America upped their target price on Doximity from $55.00 to $62.00 and gave the company a “neutral” rating in a research note on Wednesday, June 25th. Piper Sandler upped their target price on Doximity from $65.00 to $69.00 and gave the company an “overweight” rating in a research note on Monday, August 11th. Zacks Research lowered Doximity from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. Finally, Truist Financial upped their target price on Doximity from $52.00 to $61.00 and gave the company a “hold” rating in a research note on Thursday, July 17th. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $69.37.

Get Our Latest Stock Report on Doximity

Doximity Stock Performance

Shares of DOCS opened at $66.33 on Thursday. The stock has a fifty day moving average of $69.51 and a two-hundred day moving average of $61.52. The company has a market capitalization of $12.42 billion, a PE ratio of 66.33, a price-to-earnings-growth ratio of 4.10 and a beta of 1.38. Doximity, Inc. has a fifty-two week low of $40.87 and a fifty-two week high of $85.21.

Doximity (NASDAQ:DOCSGet Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.Doximity’s revenue was up 15.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.28 earnings per share. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, equities research analysts forecast that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Insider Buying and Selling at Doximity

In other Doximity news, Director Kira Scherer Wampler sold 2,000 shares of the business’s stock in a transaction on Friday, August 1st. The stock was sold at an average price of $57.09, for a total value of $114,180.00. Following the completion of the transaction, the director directly owned 16,618 shares in the company, valued at approximately $948,721.62. The trade was a 10.74% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Regina M. Benjamin sold 5,000 shares of the company’s stock in a transaction on Friday, October 10th. The stock was sold at an average price of $70.84, for a total value of $354,200.00. Following the sale, the director owned 19,839 shares of the company’s stock, valued at approximately $1,405,394.76. The trade was a 20.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 37,000 shares of company stock worth $2,635,880. Insiders own 31.30% of the company’s stock.

About Doximity

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Further Reading

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCSFree Report).

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.